Skip to product information
1 of 9

MEIBOTAN

Meibotan #India First Probiotics Blend 12.5 Billion 7 different types of Probiotics Scientifically dvascular diseases 60 Veg Capsule for (Men & Women)

Meibotan #India First Probiotics Blend 12.5 Billion 7 different types of Probiotics Scientifically dvascular diseases 60 Veg Capsule for (Men & Women)

Regular price $47.99 USD
Regular price $94.00 USD Sale price $47.99 USD
48% OFF Sold out
Shipping calculated at checkout.
  • SSL Secure Transactions
  • 14 Days Returns
  • $6.95 Shipping

Shipping & Returns

  • Tracking ID will be shared with you as soon as your order gets dispatched from our warehouse.
  • Return or exchange requests can be made within 14 days of the delivery date.
  • To return any items, please email us at order@shahifeast.com, clearly mentioning your order number and our customer support team will guide you on the process.
  • To be eligible for return, products must be in the exact condition you received them in. All packaging material must be undamaged and unused with the price tags intact.
  • Customers are advised to read our return policy for details of the return process, eligibility, refunds as well as cancellations or exchanges.
  • In case of any issues or concerns about Shipping or Returns, please contact us and we will be happy to help

Use " EXTRA10 " for 10% OFF on orders above $75

Use code " EXTRA10 " for 10% OFF at checkout on orders above $75

Features:

  • Control Blood pressure regulation
  • Maintain Cholesterol & LDL Levels
  • Serenocard is a pre-probiotic composition scientifically designed by CSIR-IMTECH focusing on the rebalancing the structural and functional changes in gut microbiota favouring prevention of cardiovascular diseases along with maintaining its immune homeostasis.
  • The gut microbiota is mechanistically linked to systemic inflammation and endothelial function.
  • Lactiplantibacillus plantarum improves endothelial function for both conduit and resistance vessels by increasing nitric oxide bioavailability and concurrently reducing systemic inflammation, as measured by brachial artery flow-mediated dilation.
  • Probiotic Lactiplantibacillus plantarum and Streptococcus thermophilus enhances nitric oxide production and enhanced nitric oxide synthase (eNOS) activity in endothelial cells for efficacious endothelial function.
  • Increased Gram-negative bacteria, lipopolysaccharide (LPS) levels compromise the cardiovascular function and increase the CVD risk. Probiotic Lacticaseibacillus rhamnosus and Prebiotic Inulin plays a significant role in reduction of LPS levels thereby mitigating the CVD risk.
  • Limosilactobacillus reuterii and Lactobacillus acidophilus lowers the levels of inflammation biomarkers TNF-α, IL-6, IL-8 thereby reducing the CVD risk.
  • Lactobacillus acidophilus increases HDL cholesterol levels thereby lowering the risk of heart disease and stroke.
  • Bifidobacterium bifidum inhibit lipid peroxidation and ROS production and, as a result, may slow or even prevent the development of CVDs and other oxidative stress-related diseases. Saccharomyces cerevisiae and its metabolites shows beneficial effect in treatment of cardiovascular diseases.
View full details